Globus Medical Inc (GMED)
75.62
+0.90
(+1.20%)
USD |
NYSE |
Nov 05, 16:00
82.76
+7.14
(+9.44%)
After-Hours: 20:00
Globus Medical Cash from Operations (Quarterly): 54.26M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 54.26M |
| March 31, 2024 | 52.39M |
| December 31, 2023 | 104.67M |
| September 30, 2023 | 50.48M |
| June 30, 2023 | 35.03M |
| March 31, 2023 | 53.31M |
| December 31, 2022 | 63.98M |
| September 30, 2022 | 32.92M |
| June 30, 2022 | 36.88M |
| March 31, 2022 | 44.69M |
| December 31, 2021 | 76.25M |
| September 30, 2021 | 77.26M |
| June 30, 2021 | 59.19M |
| March 31, 2021 | 63.57M |
| December 31, 2020 | 80.18M |
| September 30, 2020 | 53.25M |
| June 30, 2020 | 23.07M |
| March 31, 2020 | 42.29M |
| December 31, 2019 | 54.31M |
| September 30, 2019 | 55.87M |
| June 30, 2019 | 22.60M |
| March 31, 2019 | 39.20M |
| December 31, 2018 | 44.29M |
| September 30, 2018 | 51.79M |
| June 30, 2018 | 33.27M |
| Date | Value |
|---|---|
| March 31, 2018 | 52.30M |
| December 31, 2017 | 44.84M |
| September 30, 2017 | 34.80M |
| June 30, 2017 | 25.98M |
| March 31, 2017 | 53.45M |
| December 31, 2016 | 26.34M |
| September 30, 2016 | 42.65M |
| June 30, 2016 | 23.27M |
| March 31, 2016 | 55.56M |
| December 31, 2015 | 46.13M |
| September 30, 2015 | 30.05M |
| June 30, 2015 | 13.16M |
| March 31, 2015 | 34.67M |
| December 31, 2014 | 1.945M |
| September 30, 2014 | 35.64M |
| June 30, 2014 | 12.35M |
| March 31, 2014 | 29.23M |
| December 31, 2013 | 32.66M |
| September 30, 2013 | 33.56M |
| June 30, 2013 | 8.98M |
| March 31, 2013 | 18.28M |
| December 31, 2012 | 24.74M |
| September 30, 2012 | 16.90M |
| June 30, 2012 | 12.03M |
| March 31, 2012 | 22.85M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
23.07M
Minimum
Jun 2020
104.67M
Maximum
Dec 2023
55.68M
Average
53.31M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| Stryker Corp | 1.474B |
| Abbott Laboratories | 2.705B |
| Alphatec Holdings Inc | -5.342M |
| Orthofix Medical Inc | 8.984M |
| Insulet Corp | 96.50M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -10.38M |
| Cash from Financing (Quarterly) | 8.709M |
| Free Cash Flow | 161.02M |
| Free Cash Flow Per Share (Quarterly) | 0.1932 |
| Free Cash Flow to Equity (Quarterly) | 20.02M |
| Free Cash Flow to Firm (Quarterly) | 28.02M |
| Free Cash Flow Yield | 1.62% |